video Video: ImageXpress Pico Virtual Tour 29 September 2020 | By Molecular Devices Explore this virtual tour of the ImageXpress Pico Automated Cell Imaging System from Molecular Devices, including hardware and software.
news Stem cell therapy repairs Parkinson’s degeneration in mice 28 September 2020 | By Hannah Balfour (Drug Target Review) Researchers demonstrate that transplanting dopaminergic neurons grown from stem cells into the brains of mice improved motor skills.
video Video: ImageXpress Micro Confocal Virtual Tour 25 September 2020 | By Molecular Devices Explore this virtual tour of the ImageXpress Micro Confocal High-Content Imaging System from Molecular Devices, including hardware and software.
news Researchers identify drug target for treatment of malabsorption in babies 24 September 2020 | By Victoria Rees (Drug Target Review) Scientists have found a hormone peptide called YY that presents a promising drug target for malabsorption in babies.
webinar Next generation strategies for cancer immunotherapy 24 September 2020 | By PerkinElmer During this on-demand webinar, two leading researchers will discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.
whitepaper ebook: Cellular Imaging Insights 21 September 2020 | By Molecular Devices Learn how to gain insights and expedite studies for 2D and 3D cellular structures with affordable automated cellular imaging.
whitepaper Article: Imaging dataset for COVID-19 research 18 September 2020 | By Molecular Devices Molecular Devices helps Recursion produce the largest publicly available set of human cellular morphological data for COVID-19 therapeutic research.
whitepaper Interactive demo: Test drive the ImageXpress Pico Automated Cell Imaging System 17 September 2020 | By Molecular Devices A powerful, yet affordable, high-content imaging system in your own lab.
whitepaper ebook: Get a front row view of your cells 17 September 2020 | By Molecular Devices Discover how you can simplify your workflow by combining microplate reading and imaging in a small footprint.
news Engineered stem cells could evade immune system rejection, study shows 16 September 2020 | By Victoria Rees (Drug Target Review) By editing out a set of proteins on the surface of human pluripotent stem cells, researchers have ensured they will be not be rejected by the body's immune system.
news Stem cells used to identify potential treatments for Parkinson’s disease 14 September 2020 | By Victoria Rees (Drug Target Review) Scientists have found two active substances that allowed cells to reactivate the production of a protein that prevents the onset of Parkinson's disease.
whitepaper Webinar series: Considerations for successful CRISPR-based cell line engineering 11 September 2020 | By Horizon Discovery Sign up for free weekly 5-10 min videos from Horizon’s expert cell line engineers to help you improve your CRISPR editing experiments.
video On-demand webinar: Leveraging advances in predesigned synthetic sgRNA for highly functional and specific CRISPR-Cas9 gene knockout 11 September 2020 | By Horizon Discovery This webinar explains how synthetic guide RNAs are stable, eliminate cloning and sequencing steps, and avoid innate immune responses and cytotoxicity.
news Down syndrome study reveals potential leukaemia drug targets 9 September 2020 | By Hannah Balfour (Drug Target Review) The study evaluating Down syndrome endothelial cells presented novel drug targets for leukaemia and suggested why DS patients may be at greater risk from the cancer.
whitepaper Article: Common CRISPR pitfalls and how to avoid them 9 September 2020 | By Horizon Discovery This article explains how to plan a gene-editing experiment. How to choose your biological system and what reagents to get for your experimental aim.
